A SINGLE-CENTRE, PROSPECTIVE, OBSERVATIONAL AND PROOF-OF-PRINCIPLE STUDY OF PREVORA'S ABILITY TO TREAT PERI-IMPLANT MUCOSITIS.

Registry ID

2025-001

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

CHX TECHNOLOGIES INC

Last update

2025-04-07

Conditions

• ORAL MUCOSITIS

Related clinical trials

• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY OF THE SUPEROXIDE DISMUTASE MIMETIC GC4419 TO REDUCE SEVERE ORAL MUCOSITIS (SOM) ASSOCIATED WITH CHEMORADIOTHERAPY FOR LOCALLY ADVANCED, NON-METASTATIC HEAD AND NECK CANCER

View on source registry